Management of Macrocytic Anemia
Begin immediate workup with serum vitamin B12, serum and RBC folate levels, reticulocyte count, and thyroid function (TSH) to identify the underlying cause, as vitamin B12 and folate deficiencies are the most common and treatable causes of macrocytic anemia. 1, 2
Initial Diagnostic Workup
Your patient has macrocytic anemia (MCV 109.6 fL, hemoglobin 12.1 g/dL). The diagnostic algorithm proceeds as follows:
Essential First-Line Tests
Reticulocyte count to differentiate regenerative from non-regenerative causes 3, 1
Serum vitamin B12 level (deficiency defined as <150 pmol/L or <203 ng/L) 3, 1
- If B12 level is borderline, measure methylmalonic acid (>271 nmol/L confirms deficiency) 3
Serum folate and RBC folate levels 1, 2
- Serum folate <10 nmol/L (4.4 μg/L) or RBC folate <305 nmol/L (<140 mg/L) indicates deficiency 3
TSH (and free T4 if TSH abnormal) to exclude hypothyroidism 3
Medication Review
- Immediately review medications for causative agents: hydroxyurea, methotrexate, azathioprine, thiopurines 1, 2
- Consider discontinuation if clinically appropriate and medication is the likely cause 2
Additional Considerations
- Check CRP and creatinine to assess for inflammatory anemia or renal failure 3
- Evaluate RBC distribution width (RDW): an elevated RDW may indicate coexisting iron deficiency even with macrocytosis 3, 1
- If initial workup is unrevealing, consider bone marrow biopsy to evaluate for myelodysplastic syndrome 3
Treatment Algorithm
For Vitamin B12 Deficiency
Critical: Always treat B12 deficiency BEFORE initiating folate supplementation to prevent precipitating subacute combined degeneration of the spinal cord. 1, 4
Standard Regimen (Without Neurological Symptoms)
- Vitamin B12 1 mg intramuscularly three times weekly for 2 weeks 1, 2
- Then 1 mg intramuscularly every 2-3 months for life 1, 2, 4
- Avoid intravenous route as almost all vitamin will be lost in urine 4
Neurological Symptoms Present
- Hydroxocobalamin 1 mg intramuscularly on alternate days until no further improvement 1, 2
- Then 1 mg every 2 months for maintenance 1, 2
For Folate Deficiency
- Only after excluding B12 deficiency: oral folic acid 5 mg daily for minimum 4 months 1
- Doses >0.1 mg daily may mask B12 deficiency while allowing irreversible neurological damage to progress 4
For Medication-Induced Macrocytosis
- Review and discontinue causative agents when clinically appropriate 1, 2
- Monitor CBC for resolution after discontinuation 2
For Hypothyroidism
- Treat underlying thyroid disorder with thyroid hormone replacement 3
Monitoring Response to Treatment
- Monitor serum potassium closely in first 48 hours of B12 treatment and replace if necessary 4
- Repeat CBC daily from days 5-7 of therapy, then frequently until hematocrit normalizes 4
- Acceptable response: hemoglobin increase ≥2 g/dL within 4 weeks of treatment 1, 2
- Reticulocyte count should increase and remain at least twice normal while hematocrit <35% 4
- If reticulocytes fail to increase or normalize prematurely, reassess diagnosis and check for concurrent iron or folate deficiency 4
Critical Pitfalls to Avoid
- Never treat folate deficiency without first ruling out B12 deficiency - this can precipitate irreversible spinal cord damage while correcting the anemia 1, 2, 4
- Do not miss medication-induced macrocytosis - this is common and potentially reversible 1, 2
- In inflammatory conditions, ferritin may be falsely elevated despite concurrent iron deficiency; consider checking transferrin saturation and RDW 3, 1, 2
- Patients with pernicious anemia require lifelong monthly B12 injections - failure to continue will result in recurrence and irreversible neurological damage 4
- Screen patients with pernicious anemia for gastric carcinoma - they have 3 times the incidence of the general population 4